(±)-Oxanthromicin is primarily utilized in the field of medical research and pharmaceutical development due to its potential antibacterial properties. It is studied for its effectiveness against various bacterial strains, particularly those that are resistant to common antibiotics. Researchers are exploring its mechanism of action to determine its suitability as a treatment for infections caused by multidrug-resistant bacteria. Additionally, it is being investigated for its potential use in combination therapies to enhance the efficacy of existing antibiotics. The compound is also of interest in the development of new antimicrobial agents, aiming to address the growing concern of antibiotic resistance in healthcare.